BridgeBio Pharma (BBIO) earnings per share (EPS)

Earnings per share · fiscal 2025
-$3.78

BridgeBio Pharma (BBIO) reported diluted earnings per share of -$3.78 in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$2.88. Figures as of 18 Nov 2026, 01:53 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Earnings per share, fiscal 2025
-$3.78
Highest on record
-$2.88fiscal 2024
Lowest on record
-$3.95fiscal 2023
Fiscal years on record
62020–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

BridgeBio Pharma earnings per share (EPS), in more detail

Across the 6 fiscal years on record (2020–2025), the highest was -$2.88 in fiscal 2024 and the lowest -$3.95 in fiscal 2023.

History · 6 fiscal years

Earnings per share by fiscal year

BridgeBio Pharma earnings per share (EPS), year by year

BridgeBio Pharma (BBIO) earnings per share (EPS) by fiscal year
Fiscal yearEarnings per shareChangeYear ended
2025-$3.78—
2024-$2.88—
2023-$3.95—
2022-$3.26—
2021-$3.90—
2020-$3.80—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Earnings per share is net income divided by the diluted number of shares, as the company reports it; older years are re-based for later stock splits.

How to read it

It shows how much profit stands behind each share, so it rises when profit grows or when buybacks shrink the share count.

Earnings per share at health care companies of similar size

Earnings per share of BridgeBio Pharma and comparable companies
CompanyEarnings per shareFiscal year
ICON ICLR$2.712025
Jazz Pharmaceuticals JAZZ-$5.842025
Solventum SOLV$8.882025
BridgeBio Pharma BBIO-$3.782025
Summit Therapeutics SMMT-$1.442025
Glaukos GKOS-$3.282025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on BBIO

BridgeBio Pharma, figure by figure

BridgeBio Pharma (BBIO) overview: price, valuation and scorecardAll health care companies by market value

BridgeBio Pharma earnings per share (EPS): questions and answers

What is BridgeBio Pharma's diluted earnings per share?

BridgeBio Pharma (BBIO) reported diluted earnings per share of -$3.78 in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$2.88.

What are the highest and lowest diluted earnings per share figures on record for BridgeBio Pharma?

Across the 6 fiscal years on record (2020–2025), the highest was -$2.88 in fiscal 2024 and the lowest -$3.95 in fiscal 2023.

How is BridgeBio Pharma's diluted earnings per share calculated?

Earnings per share is net income divided by the diluted number of shares, as the company reports it; older years are re-based for later stock splits.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “BridgeBio Pharma (BBIO) earnings per share (EPS)”, data as of 18 November 2026. https://funkfolio.com/stock/BBIO/eps

Underlying data: the company's filings with the SEC and Yahoo Finance.